Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
East Indian sandalwood oil cream is a topical botanical preparation derived from the essential oil of the Santalum album tree (East Indian sandalwood). The active ingredient—East Indian sandalwood oil (EISO)—is rich in alpha- and beta-santalol and has demonstrated anti-inflammatory, antimicrobial, and antiproliferative properties. Its mechanism of action includes inhibition of phosphodiesterase enzymes (notably PDE4), leading to reduced pro-inflammatory cytokine production and suppression of NF-κB activation. Clinically, EISO creams have shown promise in treating inflammatory skin conditions such as atopic dermatitis (eczema), psoriasis, acne vulgaris, molluscum contagiosum, common warts (condylomata acuminata), and other dermatological disorders. The product has been developed for topical use with a favorable safety profile[2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on east indian sandalwood oil cream.